Joel S. Freundlich, Associate Professor, Medicinal Chemistry, Department Of Pharmacology, Physiology & Neuroscience, Rutgers Medical School
Engineering Platforms for Infectious Disease Research
Fri, 23 September, 2022
2:00pm - 3:00pm
Dr. Joel Freundlich, Professor of Pharmacology, Physiology and Neuroscience and of Medicine at Rutgers University
The Department of Chemistry Presents, an Online and In-person Presentation: Joel S, Freundlich, Associate Professor, Medicinal Chemistry, Department Of Pharmacology, Physiology & Neuroscience, Rutgers Medical School
Infectious diseases are responsible for millions of cases and mortalities per annum throughout the world. In response, clinicians have an array of anti-infective drugs to treat patients. However, these therapeutics are insufficient due to the continued appearance and spread of drug resistance. A race has been established between human and infectious microorganism. Can we learn how to arrive at a new therapeutic strategy for a given infection and, in the process, can we also understand more about the fundamental biological vulnerabilities of the causative microbe? This seminar will explore recent developments in our laboratory to design and leverage new platforms for the discovery of innovative therapeutic strategies. Featured will be the computational, chemical, and biological techniques integral to the platforms and their deliverables in terms of both molecule and target.
Bio
Joel S. Freundlich, Ph.D., is a Professor of Pharmacology, Physiology and Neuroscience and of Medicine at Rutgers University–New Jersey Medical School. Prior to his return to academic research, he spent eight years in the pharmaceutical industry as a medicinal chemist. His undergraduate and master’s degree training were in chemical engineering at Cornell University as a McMullen Dean’s Scholar. He received his doctorate in organic chemistry from the Massachusetts Institute of Technology under the tutelage of 2005 Nobel Prize awardee in Chemistry, Richard Schrock.
Research Interests
Computational modeling and drug design, Chemical Synthesis, Metabolomics